Literature DB >> 36187871

An extended picture fuzzy multicriteria group decision analysis with different weights: A case study of COVID-19 vaccine allocation.

Tarifa Almulhim1, Igor Barahona2.   

Abstract

The high contagion rates of COVID-19 and the limited amounts of vaccines forced public health authorities to develop vaccinations strategies for minimizing mortality, avoiding the collapse of health care infrastructure, and reducing their negative impacts to societies and economies. We propose a Multi Criteria Group Decision Making for prioritizing a set of COVID-19 vaccination alternatives, under a picture fuzzy environment, where the weights for Decisions Experts (DE) and criteria are unknown. A panel of six DEs assess six criteria for prioritizing four groups for vaccination. The weights for DE and criteria are handled in the form of fuzzy sets. Three types of weights are calculated: subjective, objective, and mixture weights. According to our results, three out of the six criteria hold 60% of the strategic importance: 1) allocation and distribution, 2) COVID-19 strains and 3) capabilities and infrastructures. However, persons with comorbidities became the group with the highest priority, followed by essential workers, women, and adults older than 40 years. Governments, decision makers, and policy makers can find rigorous scientific evidence for articulating effective vaccinations campaigns from this work, and contribute to minimize undesired outputs, such as high mortality rates or collapse of hospitals.
© 2022 The Authors. Published by Elsevier Ltd.

Entities:  

Keywords:  COPRAS; COVID-19; Multicriteria group decision making; Picture fuzzy environment; Vaccination

Year:  2022        PMID: 36187871      PMCID: PMC9508697          DOI: 10.1016/j.seps.2022.101435

Source DB:  PubMed          Journal:  Socioecon Plann Sci        ISSN: 0038-0121            Impact factor:   4.641


  26 in total

1.  CDC names H1N1 vaccine priority groups.

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2009-09-16       Impact factor: 56.272

2.  Inter-basin water transfer planning with grey COPRAS and fuzzy COPRAS techniques: A case study in Iranian Central Plateau.

Authors:  Abbas Roozbahani; Hamed Ghased; Mehdi Hashemy Shahedany
Journal:  Sci Total Environ       Date:  2020-04-12       Impact factor: 7.963

3.  Novel dynamic fuzzy Decision-Making framework for COVID-19 vaccine dose recipients.

Authors:  O S Albahri; A A Zaidan; A S Albahri; H A Alsattar; Rawia Mohammed; Uwe Aickelin; Gang Kou; F M Jumaah; Mahmood M Salih; A H Alamoodi; B B Zaidan; Mamoun Alazab; Alhamzah Alnoor; Jameel R Al-Obaidi
Journal:  J Adv Res       Date:  2021-08-21       Impact factor: 12.822

4.  COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

Authors:  S A Meo; I A Bukhari; J Akram; A S Meo; D C Klonoff
Journal:  Eur Rev Med Pharmacol Sci       Date:  2021-02       Impact factor: 3.507

5.  Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate?

Authors:  Luciano Mutti; Francesca Pentimalli; Giovanni Baglio; Patrizia Maiorano; Rita Emilena Saladino; Pierpaolo Correale; Antonio Giordano
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

6.  The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.

Authors:  Kathleen Dooling; Nancy McClung; Mary Chamberland; Mona Marin; Megan Wallace; Beth P Bell; Grace M Lee; H Keipp Talbot; José R Romero; Sara E Oliver
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-12-11       Impact factor: 17.586

7.  An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic.

Authors:  Mehdi Rastegar; Madjid Tavana; Afshin Meraj; Hassan Mina
Journal:  Vaccine       Date:  2020-12-09       Impact factor: 3.641

8.  Distance education tool selection using novel spherical fuzzy AHP EDAS.

Authors:  Akın Menekşe; Hatice Camgöz Akdağ
Journal:  Soft comput       Date:  2022-01-24       Impact factor: 3.643

9.  COVID-19 Vaccines in the Pipeline, Are Antibodies Adequate?

Authors:  Md Kamal Hossain; Majid Hassanzadeganroudsari; Jack Feehan; Vasso Apostolopoulos
Journal:  Vaccines (Basel)       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.